• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.一项基于人群的病例对照研究:输血、麻醉、手术与非霍奇金淋巴瘤风险
Int J Cancer. 2008 Aug 15;123(4):888-94. doi: 10.1002/ijc.23561.
2
Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.人体测量学、身体活动、相关医疗状况与非霍奇金淋巴瘤风险
Cancer Causes Control. 2005 Dec;16(10):1203-14. doi: 10.1007/s10552-005-0358-7.
3
Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use.女性非霍奇金淋巴瘤:生殖因素与外源性激素使用
Am J Epidemiol. 2008 Aug 1;168(3):278-88. doi: 10.1093/aje/kwn119. Epub 2008 Jun 10.
4
Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.生殖因素、绝经激素治疗与非霍奇金弥漫大 B 细胞淋巴瘤和滤泡性淋巴瘤风险:一项英国病例对照研究。
Cancer Causes Control. 2010 Dec;21(12):2079-83. doi: 10.1007/s10552-010-9626-2. Epub 2010 Aug 10.
5
Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").使用医疗保险理赔数据(“MedWAS”)对与非霍奇金淋巴瘤风险相关的医疗状况进行综合评估。
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1105-13. doi: 10.1158/1055-9965.EPI-16-0212. Epub 2016 Apr 26.
6
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.基于人群的病例对照研究中,组织学和 t(14;18)定义的非霍奇金淋巴瘤亚型的危险因素。
Int J Cancer. 2011 Aug 15;129(4):938-47. doi: 10.1002/ijc.25717. Epub 2010 Nov 23.
7
Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.非霍奇金淋巴瘤患者的心血管死亡率:根据淋巴瘤亚型的差异。
Hematol Oncol. 2019 Aug;37(3):261-269. doi: 10.1002/hon.2607. Epub 2019 Apr 12.
8
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.美国非霍奇金淋巴瘤的流行:1992-2009 年,解析 HIV 的影响。
Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1069-78. doi: 10.1158/1055-9965.EPI-13-0040. Epub 2013 Apr 17.
9
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.1973年至1998年美国卡波西肉瘤和非霍奇金淋巴瘤发病率的趋势。
J Natl Cancer Inst. 2002 Aug 21;94(16):1204-10. doi: 10.1093/jnci/94.16.1204.
10
Family history of hematopoietic malignancy and risk of lymphoma.造血系统恶性肿瘤家族史与淋巴瘤风险
J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293.

引用本文的文献

1
Iron Metabolism in Cardiovascular Disease.心血管疾病中的铁代谢
Adv Exp Med Biol. 2025;1480:217-236. doi: 10.1007/978-3-031-92033-2_15.
2
Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.铁代谢与心血管疾病:生理、机制与治疗靶点。
Circ Res. 2023 Feb 3;132(3):379-396. doi: 10.1161/CIRCRESAHA.122.321667. Epub 2023 Feb 2.
3
Blood Transfusion and the Risk of Cancer in the US Population: Is There an Association?美国人群中的输血与癌症风险:存在关联吗?
Clin Epidemiol. 2020 Oct 15;12:1121-1127. doi: 10.2147/CLEP.S271275. eCollection 2020.
4
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.输血史与非霍奇金淋巴瘤风险:InterLymph 汇集分析。
Cancer Causes Control. 2019 Aug;30(8):889-900. doi: 10.1007/s10552-019-01188-w. Epub 2019 Jun 4.
5
Cancer risk among 21st century blood transfusion recipients.21世纪输血受者的癌症风险。
Ann Oncol. 2017 Feb 1;28(2):393-399. doi: 10.1093/annonc/mdw555.
6
Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer.异体输血与食管癌围手术期及长期预后不良相关。
World J Surg. 2017 Jan;41(1):208-215. doi: 10.1007/s00268-016-3730-8.
7
New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy.非霍奇金淋巴瘤流行病学的新见解及其对治疗的启示。
Expert Rev Anticancer Ther. 2015 May;15(5):531-44. doi: 10.1586/14737140.2015.1023712. Epub 2015 Apr 11.
8
Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.滤泡性淋巴瘤的病史、生活方式、家族史及职业危险因素:国际淋巴瘤非霍奇金淋巴瘤亚型研究项目
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):26-40. doi: 10.1093/jncimonographs/lgu006.
9
Exploring risk factors for follicular lymphoma.探索滤泡性淋巴瘤的风险因素。
Adv Hematol. 2012;2012:626035. doi: 10.1155/2012/626035. Epub 2012 Sep 18.
10
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.基于人群的病例对照研究中,组织学和 t(14;18)定义的非霍奇金淋巴瘤亚型的危险因素。
Int J Cancer. 2011 Aug 15;129(4):938-47. doi: 10.1002/ijc.25717. Epub 2010 Nov 23.

本文引用的文献

1
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
2
Cancer after total joint arthroplasty: a meta-analysis.全关节置换术后的癌症:一项荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1532-7. doi: 10.1158/1055-9965.EPI-06-0127.
3
Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.1960年至2003年瑞典、丹麦和芬兰非霍奇金淋巴瘤的发病率:曾是一场流行病。
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1295-300. doi: 10.1158/1055-9965.EPI-05-0958.
4
Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults.成人特定感染、感染相关行为与非霍奇金淋巴瘤风险
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1102-8. doi: 10.1158/1055-9965.EPI-06-0078.
5
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.1992 - 2001年美国按世界卫生组织亚型划分的淋巴瘤发病模式。
Blood. 2006 Jan 1;107(1):265-76. doi: 10.1182/blood-2005-06-2508. Epub 2005 Sep 8.
6
Residential herbicide use and risk of non-Hodgkin lymphoma.住宅除草剂使用与非霍奇金淋巴瘤风险
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):934-7. doi: 10.1158/1055-9965.EPI-04-0730.
7
Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.非霍奇金淋巴瘤的风险以及淋巴、血液和其他癌症的家族史。
Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1415-21.
8
Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women.
Am J Epidemiol. 2004 Aug 15;160(4):325-30. doi: 10.1093/aje/kwh233.
9
Effects of general anaesthesia on inflammation.
Best Pract Res Clin Anaesthesiol. 2004 Sep;18(3):493-507. doi: 10.1016/j.bpa.2004.01.002.
10
Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.丙型肝炎病毒感染与非霍奇金淋巴瘤:美国国立癌症研究所监测、流行病学和最终结果(NCI-SEER)多中心病例对照研究结果
Int J Cancer. 2004 Aug 10;111(1):76-80. doi: 10.1002/ijc.20021.

一项基于人群的病例对照研究:输血、麻醉、手术与非霍奇金淋巴瘤风险

Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.

作者信息

Cerhan James R, Engels Eric A, Cozen Wendy, Davis Scott, Severson Richard K, Morton Lindsay M, Gridley Gloria, Hartge Patricia, Linet Martha

机构信息

Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 5905, USA.

出版信息

Int J Cancer. 2008 Aug 15;123(4):888-94. doi: 10.1002/ijc.23561.

DOI:10.1002/ijc.23561
PMID:18506687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3913466/
Abstract

The incidence of NHL has increased dramatically since at least the 1950s, and during this timeframe there has been a major increase in the use of blood transfusions, invasive surgical procedures and anesthesia, all of which can impact immune function. We evaluated these factors with NHL risk in a population-based study of 759 cases and 589 frequency-matched controls. Risk factor data were collected during in-person interviews. Unconditional logistic regression was used to estimate ORs and 95% CIs, adjusted for the matching factors. History of transfusion was associated with a 26% higher risk of NHL (95% CI 0.91-1.73), and the elevated risk was specific to transfusions first given 5-29 years before the reference date (OR = 1.69; 95% CI 1.08-2.62) and transfusions given for a medical condition (OR = 2.09; 95% CI 1.03-4.26). The total number of surgeries and dental procedures (OR = 1.53 for 26+ surgeries compared to 0-6; 95% CI 1.02-2.29) and to a lesser extent the total number of exposures to general or local/regional anesthesia (OR = 1.35 for 24+ times compared to 0-6; 95% CI 0.91-2.02) were positively associated with risk of NHL. Inclusion of transfusion and surgery or transfusion and anesthesia in the same model did not attenuate these associations. All results were broadly consistent for both DLBCL and follicular subtypes. Blood transfusions were associated with NHL risk, but appear to be a marker for underlying medical conditions. Multiple surgical procedures and/or repeated administration of anesthesia have not been previously reported to be associated with risk of NHL and these exposures warrant further evaluation.

摘要

至少自20世纪50年代以来,非霍奇金淋巴瘤(NHL)的发病率急剧上升,在此期间,输血、侵入性外科手术和麻醉的使用大幅增加,所有这些都会影响免疫功能。在一项基于人群的研究中,我们对759例病例和589例频率匹配的对照进行了评估,分析这些因素与NHL风险的关系。危险因素数据是在面对面访谈中收集的。采用无条件逻辑回归来估计比值比(OR)和95%可信区间(CI),并对匹配因素进行了调整。输血史与NHL风险高26%相关(95%CI 0.91 - 1.73),风险升高特定于在参考日期前5 - 29年首次进行的输血(OR = 1.69;95%CI 1.08 - 2.62)以及因医疗状况进行的输血(OR = 2.09;95%CI 1.03 - 4.26)。手术和牙科手术的总数(26次及以上手术与0 - 6次相比,OR = 1.53;95%CI 1.02 - 2.29)以及在较小程度上全身或局部/区域麻醉的总暴露次数(24次及以上与0 - 6次相比,OR = 1.35;95%CI 0.91 - 2.02)与NHL风险呈正相关。在同一模型中纳入输血与手术或输血与麻醉,并未减弱这些关联。弥漫性大B细胞淋巴瘤(DLBCL)和滤泡亚型的所有结果大致一致。输血与NHL风险相关,但似乎是潜在医疗状况的一个标志。此前尚未报道多次外科手术和/或反复给予麻醉与NHL风险相关,这些暴露值得进一步评估。